Concepedia

Patricia Spilman

PS

17

Publications

1.8K

Citations

15

H-Index

1999

Active since

Affiliations

Buck Institute for Research on Aging(Current)

University of California, Los Angeles

University of California, San Francisco

Patricia Spilman is an author at Buck Institute for Research on Aging specializing in medicine, alzheimer's disease, and neuroscience.

Top concepts

MedicineAlzheimer's DiseaseNeuroscienceProtective MechanismsNeurodegenerative DiseasesNeurologyPharmacologyNeuroprotectionCell BiologyCell Signaling

Publications per year

1999–2022

17

Publications

17

Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease

Patricia Spilman, Natalia Podlutskaya, Matthew J. Hart et al. · PLoS ONE · 2010 · 993 citations · Full text

In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid β-peptide of APP

D. Allan Butterfield, Verónica Galván, Miranda Bader Lange et al. · Free Radical Biology and Medicine · 2009 · 190 citations

Amyloid β-Peptide, Neurodegenerative Diseases, Alzheimer's Disease +12

Direct Transcriptional Effects of Apolipoprotein E

Veena Theendakara, Clare Peters‐Libeu, Patricia Spilman et al. · Journal of Neuroscience · 2016 · 148 citations · Full text

Genetics, Apoptosis, Cell Death +22

PrP<sup>c</sup>Glycoform Heterogeneity as a Function of Brain Region: Implications for Selective Targeting of Neurons by Prion Strains

Stephen J. DeArmond, Yin Long Qiu, Henry Sánchez et al. · Journal of Neuropathology & Experimental Neurology · 1999 · 109 citations

sAβPPα is a Potent Endogenous Inhibitor of BACE1

Clare Peters‐Libeu, Jesus Campagna, Michael Mitsumori et al. · Journal of Alzheimer s Disease · 2015 · 48 citations

Amyloid-β Protein Precursor, Potent Endogenous Inhibitor, Neurochemical Biomarkers +20

Rows per page

1–5 of 17